## Management of Severe IUGR with Abnormal Doppler at 28 Weeks **Key Point:** In severe IUGR with absent end-diastolic flow (AEDF) in the umbilical artery at 28 weeks, delivery should NOT be deferred beyond 32–34 weeks. This represents severe placental insufficiency with high risk of intrauterine fetal death. ### Classification and Significance of Umbilical Artery Doppler Abnormalities | Doppler Finding | Significance | Management | |-----------------|--------------|------------| | **Normal AEDF** | Preserved placental function | Serial surveillance, deliver at 37 weeks | | **Reduced AEDF** | Moderate placental insufficiency | Intensive surveillance, consider delivery 34–36 weeks | | **Absent AEDF (AEDF)** | Severe placental insufficiency | Corticosteroids + delivery by 32–34 weeks | | **Reversed AEDF (REDF)** | Critical placental failure | Immediate delivery (>28 weeks) or intensive monitoring | **High-Yield:** AEDF is a **high-risk** finding. The perinatal mortality and morbidity increase significantly. Standard practice is to deliver by **32–34 weeks** depending on fetal condition and neonatal facilities available. **Clinical Pearl:** At 28 weeks with AEDF, the decision to deliver is individualized based on: - Fetal heart rate monitoring (persistent abnormalities → earlier delivery) - Ductus venosus Doppler (abnormal → delivery within days) - Maternal condition - Neonatal unit capacity However, **deferring delivery beyond 34 weeks** in AEDF is not standard practice and increases the risk of intrauterine fetal death. ### Why Option 1 is the Correct Answer Delivery should **NOT** be deferred beyond 34 weeks because: 1. AEDF represents severe placental insufficiency 2. Risk of intrauterine fetal death increases significantly after 32–34 weeks 3. Neonatal outcomes at 32–34 weeks with corticosteroids are acceptable 4. Continued expectant management risks fetal loss without clear benefit ### Correct Management Pathway ```mermaid flowchart TD A[IUGR + AEDF at 28 weeks]:::outcome --> B[Administer corticosteroids]:::action A --> C[Assess ductus venosus Doppler]:::action C --> D{Ductus venosus abnormal?}:::decision D -->|Yes| E[Deliver within 24-48 hours]:::urgent D -->|No| F[Daily FHR monitoring]:::action F --> G{Persistent abnormalities?}:::decision G -->|Yes| H[Deliver by 32-34 weeks]:::action G -->|No| I[Deliver by 34 weeks]:::action ``` [cite:Williams Obstetrics 26e Ch 42; FIGO Guidelines on IUGR]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.